USask VIDO-InterVac awarded $23M for COVID-19 vaccine research

The University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has been awarded $23 million to fast-track efforts to develop a COVID-19 vaccine.